PubMed=7558421; DOI=10.1002/ijc.2910620613
Degeorges A., Hoffschir F., Cussenot O., Gauville C., Le Duc A., Dutrillaux B., Calvo F.
Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line.
Int. J. Cancer 62:724-731(1995)

PubMed=21556542; DOI=10.3892/ijo.6.2.333
Berthon P., Cussenot O., Hopwood L., Le Duc A., Maitland N.J.
Functional expression of SV40 in normal human prostatic epithelial and fibroblastic cells: differentiation pattern of nontumorigenic cell-lines.
Int. J. Oncol. 6:333-343(1995)

PubMed=11416159; DOI=10.1073/pnas.121616198; PMCID=PMC35459
Masters J.R.W., Thomson J.A., Daly-Burns B., Reid Y.A., Dirks W.G., Packer P., Toji L.H., Ohno T., Tanabe H., Arlett C.F., Kelland L.R., Harrison M., Virmani A.K., Ward T.H., Ayres K.L., Debenham P.G.
Short tandem repeat profiling provides an international reference standard for human cell lines.
Proc. Natl. Acad. Sci. U.S.A. 98:8012-8017(2001)

PubMed=11694337; DOI=10.1016/S0303-7207(01)00669-4
Avances C., Georget V., Terouanne B., Orio F. Jr., Cussenot O., Mottet N., Costa P., Sultan C.
Human prostatic cell line PNT1A, a useful tool for studying androgen receptor transcriptional activity and its differential subnuclear localization in the presence of androgens and antiandrogens.
Mol. Cell. Endocrinol. 184:13-24(2001)

PubMed=20215515; DOI=10.1158/0008-5472.CAN-09-3458; PMCID=PMC2881662
Rothenberg S.M., Mohapatra G., Rivera M.N., Winokur D., Greninger P., Nitta M., Sadow P.M., Sooriyakumar G., Brannigan B.W., Ulman M.J., Perera R.M., Wang R., Tam A., Ma X.-J., Erlander M., Sgroi D.C., Rocco J.W., Lingen M.W., Cohen E.E.W., Louis D.N., Settleman J., Haber D.A.
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Cancer Res. 70:2158-2164(2010)